Hi, was hoping for feedback on this difficult case. Main question is whether anyone has any experience trying Tepezza for patients with MG/ TED overlap.
66-year-old Caucasian male with onset of diplopia in July 2024, subsequently diagnosed with generalized MG (AChR binding antibody positive 12.60 [0-0.24]).
MG has been treated with Mestinon (pyridostigmine) now on 60 mg TID, Cellcept (mycophenolate) now on 750 mg BID, prednisone now on 5 mg daily, Rystiggo (rozanolixizumab-noli) infusion (recently received final infusion in course)- no improvement, previously received Vyvgart (efgartigimod alfa-fcab)- no improvement, considering Ultomiris (ravulizumab-cwvz) as next step.
No history of thymectomy. Of note, on pravastatin 80 mg.
History of Graves' in remission (per endo), no history of TED. Previously treated with methimazole (off treatment since Feb 2025). TPO positive 68 [0-34], TSI and TRAb normal, currently euthyroid.
I ordered baseline orbital imaging and findings are suggestive of TED. The read of the CT "Proptotic appearing globes and enlargement of the muscle bellies of the extraocular muscles with fatty attenuation and disproportionate involvement of the inferior and medial rectus muscles. Relative sparing of the anterior tendons. Constellation of findings is nonspecific, but compatible with thyroid associated orbitopathy."
Clinically he does not appear proptotic or inflamed. He does have orbital pain and obviously diplopia.
I wonder if, after a washout period since he just finished Rystiggo, whether Tepezza could be considered. I spoke to the medical liason from the drug company this morning and essentially reaffirmed lack of evidence in these types of cases. My main concern would be exacerbating his MG given the possible muscle side effects.
Thanks for your thoughts,
Ola Pietraszkiewicz
-------------------------------------------